Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2012, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2012-07-19
DOI
10.1155/2012/872713
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Subclinical phaeochromocytoma
- (2012) Massimo Mannelli et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Signaling Pathways in Pheochromocytomas and Paragangliomas: Prospects for Future Therapies
- (2012) Svenja Nölting et al. ENDOCRINE PATHOLOGY
- Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
- (2011) Jenny Welander et al. ENDOCRINE-RELATED CANCER
- Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
- (2011) Iñaki Comino-Méndez et al. NATURE GENETICS
- Malignant pheochromocytomas and paragangliomas – The importance of a multidisciplinary approach
- (2010) Kim Francis Andersen et al. CANCER TREATMENT REVIEWS
- MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets
- (2010) Goswin Y Meyer-Rochow et al. ENDOCRINE-RELATED CANCER
- SDHA is a tumor suppressor gene causing paraganglioma
- (2010) Nelly Burnichon et al. HUMAN MOLECULAR GENETICS
- Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
- (2010) Yuejuan Qin et al. NATURE GENETICS
- Incidental and Metastatic Adrenal Masses
- (2010) Massimo Mannelli et al. SEMINARS IN ONCOLOGY
- Expression of the Transcription Factor Snail and Its Target Gene Twist Are Associated with Malignancy in Pheochromocytomas
- (2009) Jens Waldmann et al. ANNALS OF SURGICAL ONCOLOGY
- High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytoma
- (2009) V Häyry et al. ENDOCRINE-RELATED CANCER
- Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001)
- (2009) M. R. Druce et al. HORMONE AND METABOLIC RESEARCH
- Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma
- (2009) K.-S. Park et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Clinically Guided Genetic Screening in a Large Cohort of Italian Patients with Pheochromocytomas and/or Functional or Nonfunctional Paragangliomas
- (2009) Massimo Mannelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hepatic ablation for neuroendocrine tumor metastases
- (2009) Shishir K. Maithel et al. JOURNAL OF SURGICAL ONCOLOGY
- The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas
- (2009) Judith Favier et al. PLoS One
- SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
- (2009) H.-X. Hao et al. SCIENCE
- Rapid degradation of hypoxia-inducible factor-1α by KRH102053, a new activator of prolyl hydroxylase 2
- (2008) H J Choi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine
- (2008) Hui Huang et al. CANCER
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- TORC1 Is Essential for NF1-Associated Malignancies
- (2008) Cory M. Johannessen et al. CURRENT BIOLOGY
- Rationale and Evidence for Sunitinib in the Treatment of Malignant Paraganglioma/Pheochromocytoma
- (2008) Anthony M. Joshua et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors
- (2008) Camilo Jimenez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient With Malignant Paraganglioma Responding to the Multikinase Inhibitor Sunitinib Malate
- (2008) Noah M. Hahn et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis
- (2008) Vivian E. Strong et al. SURGERY
- Plasma Chromogranin A or Urine Fractionated Metanephrines Follow-Up Testing Improves the Diagnostic Accuracy of Plasma Fractionated Metanephrines for Pheochromocytoma
- (2007) Alicia Algeciras-Schimnich et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation